Cell Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy Type (Allogeneic Therapies and Autologous Therapies); By Technology; By Application; By Region; Segment Forecast, 2024- 2032

Cell Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy Type (Allogeneic Therapies and Autologous Therapies); By Technology; By Application; By Region; Segment Forecast, 2024- 2032

The global cell therapy market size is expected to reach USD 24.85 billion by 2032, according to a new study by Polaris Market Research. The report “Cell Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy Team (Allogeneic Therapies and Autologous Therapies); By Technology; By Application; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Increasing prevalence of various chronic conditions, rising government assistance worldwide, and surge in the number of companies investing heavily in research & development of cell therapies, are driving the market’s growth. Additionally, growing applications of cell therapies in personalized medicine, regenerative medicine, and immunotherapy making them more prominent in the medical field.

For instance, in January 2024, Pluri, announced the launch of its new business division named “PluriCDMO”. The new business division will offer cell therapy manufacturing services like a contract development and manufacturing organization.

Furthermore, need for the cell therapies is growing drastically and in 2022 only, around 1,500 clinical trials involving cell therapies were registered with the ClinicalTrials.gov. In order to meet this rising demand, companies producing cells at unprecedented scale while maintaining the safety, quality, and efficacy. Thus, the incorporation of innovative solutions in cell production such as single-use bioreactors and 3D bioprinting are emerging at rapid pace.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/cell-therapy-market/request-for-sample

The integration of advanced technologies like 3D bioprinting and automation into cell therapies is gaining huge traction. As these technologies mainly aimed at improving the overall scalability, reduce operational costs, and ensure timely & consistent delivery of results, companies are increasingly looking to integrate these technologies into their cell therapies. For instance, in May 2023, Cellular Origins, announced the launch of Constellation, a fully automated and configurable robotic platform. It is specially designed to automate the manufacturing of advanced therapies without major process redevelopment.

Growing adoption of CAR-T cell therapies and ongoing research activities focused on enhancing or improving the safety, efficacy, and applications of these therapies for broader patient population, further escalating the market’s growth. For instance, in December 2023, Max Healthcare, introduced CAR-T cell therapy in collaboration with the ImmunoACT at its hospital in Delhi.

Cell Therapy Market Report Highlights

Autologous therapies segment accounted for largest share, on account of its increasing adoption for the treatment of genetic disorders

Somatic cell technology segment expected to hold significant share, due to rising usage of this technology in immunotherapies

Musculoskeletal segment will grow at fastest pace, that is attributed to rise in incidences of these conditions worldwide and global aging population

North America dominated the global market, owing to presence of large pharma companies and advancements in cell therapies manufacturing processes

The key market players include Merck KGaA, Precision Biosciences, Becton, Dickinson, and Company, CRISPR Therapeutics, and Thermo Fisher Scientific

Polaris Market Research has segmented the cell therapy market report based on therapy type, technology, application, and region:

Cell Therapy, Therapy Type Outlook (Revenue - USD Billion, 2023 - 2032)

Allogeneic Therapies

Autologous Therapies

Cell Therapy, Technology Outlook (Revenue - USD Billion, 2023 - 2032)

Somatic Cell Technology

Cell Immortalization Technology

Viral Vector Technology

Genome Editing Technology

Cell Plasticity Technology

Cell Therapy, Application Outlook (Revenue - USD Billion, 2023 - 2032)

Musculoskeletal

Cardiovascular

Gastrointestinal

Neurological

Oncology

Dermatology

Wound and Injuries

Ocular

Others

Cell Therapy, Regional Outlook (Revenue - USD Billion, 2023 - 2032)

North America

• U.S.
• Canada

Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands

Asia Pacific

• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia

Latin America

• Argentina
• Brazil
• Mexico

Middle East & Africa

• UAE
• Saudi Arabia
• Israel
• South Africa